MedPath

CSL BEHRING (AUSTRALIA) PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

204

TGA:204

Drug Approvals

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL pre-filled syringe (457854)

Product Name
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL pre-filled syringe
Approval Date
Feb 17, 2025
TGA

ANDEMBRY garadacimab 200 mg solution for injection in pre-filled pen (443611)

Product Name
ANDEMBRY garadacimab 200 mg solution for injection pre-filled pen
Approval Date
Jan 14, 2025
TGA

ANDEMBRY garadacimab 200 mg solution for injection in pre-filled syringe with needle safety device (428253)

Product Name
ANDEMBRY garadacimab 200 mg solution for injection pre-filled syringe with needle safety device
Approval Date
Jan 14, 2025
TGA

CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial (470325)

Product Name
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial
Approval Date
Nov 25, 2024
TGA

CSL Hong Kong Albumex 5 NexGen Human Albumin 50 g/L Solution for Intravenous Infusion (462456)

Product Name
CSL Hong Kong Albumex 5 NexGen Human Albumin 50 g/L Solution for Intravenous Infusion
Approval Date
Sep 20, 2024
TGA

CSL United States of America Privigen normal immunoglobulin (human) (100g/L, 10%) solution for intravenous solution (458605)

Product Name
CSL United States of America Privigen normal immunoglobulin (human) (100g/L, 10%) solution for intravenous solution
Approval Date
Aug 5, 2024
TGA

CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule (455126)

Product Name
CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule
Approval Date
Jul 11, 2024
TGA

CSL Malaysia Intragam NexGen MY normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion (448166)

Product Name
CSL Malaysia Intragam NexGen MY normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion
Approval Date
May 9, 2024
TGA

CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20% (445060)

Product Name
CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%
Approval Date
Apr 2, 2024
TGA

CSL Hong Kong Intragam NexGen HK normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion (444244)

Product Name
CSL Hong Kong Intragam NexGen HK normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion
Approval Date
Mar 22, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.